Clinical Efficacy of Taohua Tang and Buzhong Yiqi Tang in Treatment of Deficiency Syndrome of Crohn's Disease

Peng-fei KONG; Xian-peng WEI; Xue-gui TANG

doi:10.13422/j.cnki.syfjx.20192131

您当前的位置：

首页 >

文章列表页 >

Clinical Efficacy of Taohua Tang and Buzhong Yiqi Tang in Treatment of Deficiency Syndrome of Crohn's Disease

Clinic | 更新时间：2021-02-09

- Clinical Efficacy of Taohua Tang and Buzhong Yiqi Tang in Treatment of Deficiency Syndrome of Crohn's Disease
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 24, Pages: 54-59(2019)
- 作者机构：
  
  1.川北医学院　附属医院，四川　南充　 637001；
  2.川北医学院，四川　南充　 637000
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20192131
  CLC： R5; R57; R572; R574
- Received：12 June 2019，
  
  Published Online：16 August 2019，
  
  Published：20 December 2019
- 稿件说明：
移动端阅览
Peng-fei KONG, Xian-peng WEI, Xue-gui TANG. Clinical Efficacy of Taohua Tang and Buzhong Yiqi Tang in Treatment of Deficiency Syndrome of Crohn's Disease[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(24): 54-59.
DOI：

Peng-fei KONG, Xian-peng WEI, Xue-gui TANG. Clinical Efficacy of Taohua Tang and Buzhong Yiqi Tang in Treatment of Deficiency Syndrome of Crohn's Disease[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(24): 54-59. DOI： 10.13422/j.cnki.syfjx.20192131.

摘要

目的：

观察桃花汤合补中益气汤加减治疗克罗恩病(CD)活动期(脾胃虚寒证)的疗效及对Th1和Th17细胞因子的影响。

方法：

将86例CD患者根据随机按数字表法分成对照组42和观察组44例。对照组轻度，口服柳氮磺吡啶(SASP)肠溶片，3～4 g·d

－1

，3次/d；中度或柳氮磺吡啶肠溶片效果不好者，口服醋酸泼尼松片，0.75 mg·kg

－1

·d

－1

，3次/d。观察组西医治疗同对照组，内服桃花汤合补中益气汤加减，1剂/d。两组疗程均为连续治疗12周。进行治疗前后Best 的克罗恩病活动指数(Best CDAI)，CD 简化内镜评分(SES-CD)，脾胃虚寒证和炎症性肠病问卷(IBDQ)评分；检测治疗前后C反应蛋白(CRP)，红细胞沉降率(ESR)，清蛋白(ALB)，血红蛋白(HB)，血小板计数(PLT)，干扰素-

(INF-

)，肿瘤坏死因子-

(TNF-

)，白细胞介素-2(IL-2)和IL-17水平。

结果：

治疗后观察组中医证候疗效优于对照组(

＝2.058，

0.05)；观察组临床缓解率、有效率和内镜下缓解率分别为93.18%，100%和86.36%，分别高于对照组的76.19%，83.33%和66.67%(

0.05)；观察组患者Best CDAI，SES-CD和脾胃虚寒证评分均低于对照组(

0.01)，IBDQ评分高于对照组(

0.01)；治疗后观察组患者CD活动情况轻于对照组(

＝2.112，

0.05)；观察组患者炎症程度轻于对照组(

＝2.288，

0.05)；观察组患者CRP，ESR和PLT水平均低于对照组(

0.01)，ALB和HB水平均高于对照组(

0.01)；观察组患者INF-

，TNF-

，IL-2和IL-17水平均低于对照组(

0.01)。

结论：

在常规西医治疗的基础上，内服桃花汤合补中益气汤加减治疗CD活动期脾胃虚寒证患者，可控制疾病的活动度，减轻病情程度和炎症反应，提高缓解率和生活质量，临床疗效优于单纯的西医治疗。

Abstract

Objective:

To observe clinical efficacy of Taohua Tang and Buzhong Yiqi Tang on Crohn's disease (CD) at active phase (deficiency-cold in spleen and stomach)

in order to observed its effect on Th1 and Th17 cytokines.

Method:

According to random number table

86 patients with CD were divided into control group (42 cases) and observation group (44 cases). The control group (mild) was given SASP

3-4 g·d

-1

tid

. The control group (moderate or poor efficacy of SASP) was given prednisone acetate

0.75 mg·kg

-1

·d

-1

tid

. Observation group was given Taohua Tang and Buzhong Yiqi Tang in addition to therapy of the control group

1 dose·d

-1

. The course of treatment was 12 weeks. Before and after treatment

Best CDAI

SES-CD

IBDQ and deficiency syndrome were scored

and levels of CRP

ESR

ALB

PLT

IFN-

TNF-

IL-2 and IL-17 were measured before and after treatment.

Result:

After treatment

the effect of traditional Chinese medicine(TCM) syndromes in the observation group was better than that in the control group (

= 2.058

0.05). The clinical remission rate

the effective rate and the endoscopic remission rate in the observation group were 93.18%

100% and 86.36%

which were higher than 76.19%

83.33% and 66.67% in the control group (

0.05). Best CDAI

SES-CD and IBDQ scores of the observation group were lower than those of the control group (

0.01)

while IBDQ score was higher than that of the control group (

0.01). CD activity in the observation group was lower than that in the control group (

= 2.112

0.05). The degree of inflammation in the observation group was lighter than that in the control group (

= 2.288

0.05). CRP

ESR and PLT levels in the observation group were lower than those in the control group (

0.01)

whereas ALB and HB levels were higher than those in the control group (

0.01). IFN-

TNF-

IL-2 and IL-17 levels in the observation group were lower than those in the control group (

0.01).

Conclusion:

In addition to the therapy of conventional western medicine

Taohua Tang and Buzhong Yiqi Tang in treatment of deficiency syndrome of Crohn's disease (CD) can control the activity degree of the disease

reduce the degree of illness and inflammation

and improve the remission rate and the quality of life

with a better clinical efficacy than the pure western medicine therapy.

关键词

Keywords

references

中华医学会消化病学分会炎症性肠病学组．炎症性肠病诊断与治疗的共识意见(2018年·北京) [J]．中国实用内科杂志， 2018 ， 38 ( 9 )： 796 - 813 ．

李菁，钟丽坤，梁列新．克罗恩病诊断及疾病评估方法的研究进展 [J]．广西医学， 2017 ， 39 ( 5 )： 693 - 695 ．

王园园，张驰，刘红华，等．中医药治疗克罗恩病的研究进展 [J]．湖南中医杂志， 2018 ， 34 ( 11 )： 168 - 170 ．

赵延华，赵智强．略论克罗恩病的中医认识 [J]．南京中医药大学学报， 2014 ， 30 ( 5 )： 410 - 412 ．

吴璐一，季光，赵继梦，等．中医药治疗克罗恩病的研究与思考 [J]．环球中医药， 2014 ， 7 ( 5 )： 393 - 397 ．

陈佳，姜小帆，马寅伍．小柴胡汤合桃花汤治疗溃疡性结肠炎疗效观察及对炎症因子的影响研究 [J]．现代中医药， 2018 ， 38 ( 6 )： 61 - 63＋70 ．

李强，郭蕾，陈少丽，等．补中益气汤治疗胃肠病的实验研究进展 [J]．中成药， 2016 ， 38 ( 6 )： 1360 - 1363 ．

崔成成，叶柏．叶柏教授治疗克罗恩病经验 [J]．长春中医药大学学报， 2016 ， 32 ( 5 )： 938 - 940 ．

中华医学会消化病学分会炎症性肠病学组．炎症性肠病诊断与治疗的共识意见(2012年·广州) [J]．中华内科杂志， 2012 ， 51 ( 10 )： 818 - 831 ．

李乾构，周学文，单兆伟．中医消化病诊疗指南 [M]．北京：中国中医药出版社， 2006 ： 75 - 78 ．

高永健，钱家鸣，朱峰，等．炎症性肠病患者生存质量问卷调查研究 [J]．中国全科医学， 2012 ， 15 ( 17 )： 1974 - 1976 ．

夏盛隆，薛战雄，蔡振寨，等． Th1，Th2和Th17细胞失衡与克罗恩病的关系 [J]．胃肠病学， 2017 ， 22 ( 6 )： 331 - 336 ．

巫协宁．克罗恩病的治疗策略和机制 [J]．国际消化病杂志， 2017 ， 37 ( 5 )： 306 - 310 ．

巫协宁，吴坚炯．克罗恩病治疗的新理念 [J]．胃肠病学和肝病学杂志， 2018 ， 27 ( 5 )： 483 - 487 ．

王玥，姜相君．克罗恩病的药物治疗进展 [J]．中国医刊， 2017 ， 52 ( 1 )： 26 - 30 ．

田明健，肖瑞崇，李东书．基于经典理论和文献资料探讨克罗恩病中医诊疗 [J]．辽宁中医药大学学报， 2017 ， 19 ( 9 )： 156 - 158 ．

钟燕桃，陈延．广东地区克罗恩病的中医证型分布特征研究 [J]．中医临床研究， 2017 ， 9 ( 18 )： 107 - 110 ．

袁嘉伟，张義捷，黄礼睿，等．血清学优化指标在克罗恩病黏膜愈合判断中的诊断效能 [J]．现代消化及介入诊疗， 2018 ， 23 ( 2 )： 156 - 159 ．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Traditional Chinese Medicine Intervention for Ferroptosis in Treatment of Inflammatory Bowel Disease： A Review

Clinical Efficacy of Modified Banxia Xiexintang Combined with Vedolizumab in Treatment of Crohn's Disease with Syndrome of Cold and Heat in Complexity

Shenling Baizhusan Alleviates Intestinal Inflammation in Rat Model of Crohn's Disease via p38 MAPK Pathway

Top 10 Academic Progress of Traditional Chinese Medicine in 2022

Effect of Buzhong Yiqi Tang on Cisplatin Resistance A549/DDP Cells in Nude Mice with Lung Adenocarcinoma

Related Author

ZHAO Dejie

SHANG Mingrong

ZHAO Yanan

ZHANG Xuyang

CUI Huifang

ZHAO Yijing

LIU Ming

JI Zhenliao

Related Institution

Affiliated Hospital of Shandong University of TCM

Shandong University of Traditional Chinese Medicine（TCM）

The Second Affiliated Hospital of Hainan Medical University

The First Hospital of Hunan University of Chinese Medicine

Hunan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰